Gene Query: GNG4

Dataset Description Geneva Score
Transcriptomic analysis of human tonsillar TFH subsets 60.57
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 51.83
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 51.83
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 51.09
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 45.18
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 44.03
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 43.09
Dtx3L and Androgen Signaling in Prostate Cancer 39.46
Gene expression changes after LOC550643 silencing 37.9
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 36.99
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 36.88
Transcriptional responses of human insulinoma cells to acute cytokine exposure 35.82
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 34.92
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 34.71
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 34.09
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 33.24
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 31.8
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 31.76
TGF-β promotes genomic instability after loss of RUNX3 29.34
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 28.52
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 27.71
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 27.3
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 24.87
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 24.52
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 24.52
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 22.9
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 22.9
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 22.73
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 22.73
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 22.53
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 21.72
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 21.72
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 21.31
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 20.2
Examining serotonergic neuron differentiation from human iPSCs 19.28
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 19.21
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 18.97
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 18.61
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 17.56
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 17.52
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 17.43
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 17.34
DJ-1 is dispensable for human stem cell homeostasis 16.98
Epigenomic landscape during organ formation in human early embryos 16.96
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 16.69
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 16.62
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 16.53
The MEF2B Regulatory Network - RNA-seq data 16.43
The MEF2B Regulatory Network 16.43
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 16.22
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 15.98
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 15.97
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 15.76
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 15.66
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 15.64
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 15.22
Characterization of human ILC2 subsets 15.19
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 15.01
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 15.01
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 14.43
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 14.43
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 13.83
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 13.75
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 13.75
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 13.63
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 13.61
Targeting EZH2 in MYCN-amplified Neuroblastoma 13.61
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 13.6
Regionally specified human pluripotent stem cell-derived astrocytes 13.43
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 13.22
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 13.06
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 13.05
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 12.95
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 12.95
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 12.76
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 12.76
DIGIT regulates endoderm differentiation of human embryonic stem cells 12.71
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 12.71
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 12.7
Transcriptome analysis of BAP1 knockout and restoration 12.6
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 12.6
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 12.48
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 12.48
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 12.32
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 12.25
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 12.16
RNA sequencing of human pancreatic cancer cell lines 12.1
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 12.05
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 12.05
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 11.77
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 11.38
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 11.38
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 11.37
R430: A potent inbibitor of DNA and RNA viruses 11.26
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 11.22
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 11.07
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 11.04
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 10.63
RNA-seq analysis of RALD iPSCs after in vitro differentiation 10.59
Transcriptomic and gene ontology profiling of the human corneal cell types 10.43
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 10.42
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 10.42
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 10.4
RNA sequencing of BT142 and TS603 cell lines 10.32
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 10.32
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 10.29
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 10.28
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 10.23
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 10.22
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 10.18
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 10.18
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 10.16
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 10.03
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 10.01
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 9.99
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 9.86
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 9.76
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 9.7
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 9.48
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 9.45
Identifying the molecular mode of action of itraconazole in colorectal cancer 9.43
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 9.42
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 9.35
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 9.32
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 9.28
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 9.22
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 9.1
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 9.0
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 9.0
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 8.94
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 8.94
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 8.93
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 8.88
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 8.87
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 8.84
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 8.81
Controlling for gene expression changes in transcription factor protein networks. 8.81
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 8.78
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 8.74
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 8.73
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 8.71
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 8.63
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 8.61
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 8.61
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 8.44
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 8.44
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 8.38
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 8.37
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 8.28
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 8.03
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 7.99
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 7.83
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 7.79
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 7.79
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 7.77
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 7.68
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 7.53
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 7.53
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 7.51
The cytokine environment influence on human skin-derived T cells 7.44
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 7.42
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 7.37
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 7.36
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 7.36
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 7.33
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 7.33
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 7.31
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 7.3
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 7.28
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 7.28
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 7.28
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 7.21
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 7.13
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 7.1
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 7.06
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 7.02
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 6.95
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 6.9
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 6.85
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 6.85
Rorc disruption in human FG pancreatic cancer cells 6.82
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 6.81
Next generation sequencing of small RNAs isolated from exosomes in human semen 6.79
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 6.76
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 6.76
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 6.73
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 6.73
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 6.68
RNA seq_PDX2_SHP099 6.66
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 6.65
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 6.61
Global epigenomic reconfiguration during mammalian brain development 6.59
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 6.58
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 6.55
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 6.49
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 6.44
Evolution of a transcriptional regulator from a transmembrane nucleoporin 6.43
RNA-seq in HepG2 and IMR90 cells 6.43
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 6.41
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 6.4
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 6.36
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 6.25
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 6.23
Disruption of the exocyst induces podocyte loss and dysfunction 6.18
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 6.15
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 6.14
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 6.14
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 6.13
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 6.13
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 6.12
Total RNA sequencing of APC mutant and wt colonic organoids 6.03
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 5.98
Spliceosomal disruption of the non-canonical BAF complex in cancer 5.96
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 5.94
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 5.93
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 5.93
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 5.91
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 5.79
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 5.78
Co-regulation of splicing by Rbfox1 and hnRNP M 5.76
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 5.76
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 5.76
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 5.72
High-Throughput Kinetic Analysis of Fractional Killing 5.72
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 5.58
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 5.52
Effect of disulfiram treatment on pediatric high grade glioma 5.5
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 5.44
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 5.44
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 5.43
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 5.43
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 5.43
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 5.42
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 5.38
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 5.31
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 5.31
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 5.31
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 5.3
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 5.29
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 5.28
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 5.24
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 5.2
Human islets of varying quality: the good, the (not so) bad and the ugly 5.15
Global analysis of alternative splicing regulated by RBM10 5.14
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 5.13
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 5.12
High-efficiency RNA-based reprogramming of human primary fibroblasts 5.12
Global transcriptome analysis of HAP1 cells 5.11
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 5.06
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 5.05
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 5.03
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 5.03
Differentially expressed vascular development genes for iPSC-ECs from CDI 5.02
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 4.99
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 4.98
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 4.98
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 4.97
Global expression profiles in cardiac progenitor cells generated by ISX-9 4.97
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 4.91
Dissecting neural differentiation regulatory networks through epigenetic footprinting 4.89
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 4.89
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 4.88
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 4.87
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 4.85
T47D RNA-seq and ChrRNA-seq data 4.81
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 4.81
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 4.76
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 4.76
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 4.74
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 4.71
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 4.66
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 4.66
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 4.65
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 4.65
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 4.65
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 4.63
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 4.63
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 4.61
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 4.61
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 4.6
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 4.59
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 4.54
Gene expression profiling in metabolically heterogeneous human lung tumors 4.54
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 4.52
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 4.49
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 4.42
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 4.41
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 4.39
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq Human] 4.38
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 4.38
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 4.37
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 4.28
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 4.28
Gene expression analysis of dengue-infected cells 4.28
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 4.23
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 4.2
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 4.16
RNA-seq of SCLC PDX models treated with EP 4.14
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 4.06
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 4.04
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 3.99
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 3.98
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 3.98
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 3.98
Transcriptional effect of ETV1 knockdown in melanoma cells 3.96
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 3.96
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 3.95
The DPYSL2 gene connects mTOR and schizophrenia 3.95
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 3.9
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 3.85
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 3.83
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 3.76
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 3.7
Repurposing of promoters and enhancers during mammalian evolution 3.69
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 3.68
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 3.67
Human HAP1 cells before and after nutrient deprivation 3.64
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 3.64
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 3.63
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 3.58
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 3.55
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 3.53
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 3.53
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 3.53
Total RNA sequencing of WT intestinal orgaonids. 3.49
RNA-seq of naive and primed ES cells (NHSM) 3.47
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 3.46
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 3.46
Transcriptional dependencies in diffuse intrinsic pontine glioma 3.46
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 3.41
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 3.4
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 3.4
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 3.39
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 3.37
Role of FGFR1 in neuronal devlopment 3.32
NKX2.2 3.32
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 3.32
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 3.3
TGF-β regulation of miRNA expression in pancreatic cancer 3.23
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 3.17
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 3.17
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 3.16
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 3.16
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 3.13
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 3.13
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 3.08
Comparative Analysis of Cas9 Activators Across Multiple Species 3.07
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 3.01
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 2.96
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 2.94
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 2.93
Functional Haploid Human Oocytes Generated from Polar Body Genomes 2.93
FGF2 regulation of gene expression in stable inducible Neurons 2.9
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 2.88
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 2.85
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 2.85
Generating Patterned Kidney Organoids for Studying Development and Diseases 2.8
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 2.8
RNA-Seq analysis of human colorectal cancer with liver metastasis 2.8
Functional astrocytes differentiated from hiPSCs 2.79
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 2.72
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 2.72
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 2.71
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 2.69
Endometrial transcriptome and PGR cistrome in cycling fertile women 2.69
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 2.63
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 2.62
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 2.59
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 2.59
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 2.59
Activity-dependent transcriptional changes in human neurons 2.56
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 2.53
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 2.53
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 2.52
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 2.5
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 2.5
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 2.47
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 2.46
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 2.41
CUREfast: Accelerating research with families 2.41
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 2.39
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 2.37
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 2.37
HEK293 TFAM Knockout Expression Study 2.36
Iron response of HepG2 cells 2.35
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 2.33
Proliferation-correlated expression 2.25
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 2.23
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 2.21
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 2.21
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 2.17
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 2.17
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 2.15
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 2.15
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 2.13
Entrectinib Resistance in a Neuroblastoma Xenograft Model 2.1
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 2.08
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 2.05
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 2.04
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 2.03
Hepatic transcriptome of pediatric hepatoblastoma. 1.99
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 1.97
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 1.95
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 1.94
RNA-seq in endometrial stromal tumors 1.93
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 1.92
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 1.91
RNA splicing alteration on glioblastoma and normal neural stem cells 1.89
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 1.89
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 1.86
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 1.83
Disruption of GRIN2B impairs differentiation in human neurons 1.81
nELAVL HITS-CLIP in Alzheimer's Disease patients 1.78
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 1.78
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 1.78
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 1.65
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.59
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 1.57
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 1.52
Leucegene: ALL sequencing 1.51
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 1.48
RNA-Seq of the corpus callosum from 12 individuals 1.47
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 1.43
Primate-specific gene TMEM14B promotes cortical expansion and folding 1.43
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 1.4
RNA-seq analysis of gene expression patterns during hESC neural differentiation 1.39
hESC neural differentiation 1.39
Multiple sclerosis and EAE 1.35
Human optic chiasm from healthy controls and multiple sclerosis patients 1.35
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 1.34
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 1.31
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 1.3
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 1.27
Dynamic 3D chromosomal landscapes in acute leukemia 1.27
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 1.25
Expression profiles of the four human major ectodermal lineages 1.25
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 1.23
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 1.2
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 1.17
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 1.15
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 1.15
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 1.12
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 1.07
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 1.07
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 1.04
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 1.03
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 1.0
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 0.99
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.98
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 0.93
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 0.93
The role of CFTR in islet function 0.89
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 0.87
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 0.86
The Glioma-Infiltrating T Cell Receptor Repertoire 0.83
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 0.82
RNA seq comparison between scrambled and shGRP78 cells 0.79
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 0.77
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 0.77
Zika virus directly infects human peripheral neurons and induces cell death 0.75
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 0.74
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 0.73
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.71
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.71
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 0.67
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 0.64
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.6
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 0.55
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 0.43
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.43
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 0.43
RNA-seq of cancer cell lines treated with T-025 0.41
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.41
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.4
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.37
Effect of nuclear IL-33 on gene expression 0.37
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 0.37
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 0.33
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.32
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.32
hNSCs siRNA NOVA2 0.29
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.28
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.25
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 0.22
The effect of insulin on mRNA transcription of human pluripotent stem cells 0.2
Engineering Patient-Specific Tissue Implants 0.19
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.17
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.17
A single-cell transcriptome atlas of the human pancreas 0.15
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 0.13
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 0.1
The chromatin modifier CHD8 targets autism risk genes during human neurodevelopment  0.1
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 0.09
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 0.09
RNA-Seq in PWS iPSC-derived neurons 0.08
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 0.08
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 0.04
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 0.03
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.02
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation